These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter. Cameron KN; Kolanos R; Solis E; Glennon RA; De Felice LJ Br J Pharmacol; 2013 Apr; 168(7):1750-7. PubMed ID: 23170765 [TBL] [Abstract][Full Text] [Related]
9. Effect of the combination of mephedrone plus ethanol on serotonin and dopamine release in the nucleus accumbens and medial prefrontal cortex of awake rats. López-Arnau R; Buenrostro-Jáuregui M; Camarasa J; Pubill D; Escubedo E Naunyn Schmiedebergs Arch Pharmacol; 2018 Mar; 391(3):247-254. PubMed ID: 29349706 [TBL] [Abstract][Full Text] [Related]
10. Combined effects of mephedrone and cocaine on locomotor activity and conditioned place preference in male Sprague-Dawley rats. Kohler RJ; Cibelli J; Baker LE Behav Pharmacol; 2020 Jun; 31(4):368-377. PubMed ID: 32032101 [TBL] [Abstract][Full Text] [Related]
11. Mephedrone interactions with cocaine: prior exposure to the 'bath salt' constituent enhances cocaine-induced locomotor activation in rats. Gregg RA; Tallarida CS; Reitz AB; Rawls SM Behav Pharmacol; 2013 Dec; 24(8):684-8. PubMed ID: 24126218 [TBL] [Abstract][Full Text] [Related]
12. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Baumann MH; Ayestas MA; Partilla JS; Sink JR; Shulgin AT; Daley PF; Brandt SD; Rothman RB; Ruoho AE; Cozzi NV Neuropsychopharmacology; 2012 Apr; 37(5):1192-203. PubMed ID: 22169943 [TBL] [Abstract][Full Text] [Related]
13. Effects of D1 and D2 receptor antagonists on the discriminative stimulus effects of methylendioxypyrovalerone and mephedrone in male Sprague-Dawley rats trained to discriminate D-amphetamine. Harvey EL; Burroughs RL; Baker LE Behav Pharmacol; 2017 Oct; 28(7):586-589. PubMed ID: 28704276 [TBL] [Abstract][Full Text] [Related]
14. Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat. Shortall SE; Macerola AE; Swaby RT; Jayson R; Korsah C; Pillidge KE; Wigmore PM; Ebling FJ; Richard Green A; Fone KC; King MV Eur Neuropsychopharmacol; 2013 Sep; 23(9):1085-95. PubMed ID: 23051939 [TBL] [Abstract][Full Text] [Related]
15. Abuse-related neurochemical and behavioral effects of cathinone and 4-methylcathinone stereoisomers in rats. Hutsell BA; Baumann MH; Partilla JS; Banks ML; Vekariya R; Glennon RA; Negus SS Eur Neuropsychopharmacol; 2016 Feb; 26(2):288-297. PubMed ID: 26738428 [TBL] [Abstract][Full Text] [Related]
16. Effects of repeated treatment with methcathinone, mephedrone, and fenfluramine on intracranial self-stimulation in rats. Suyama JA; Banks ML; Negus SS Psychopharmacology (Berl); 2019 Mar; 236(3):1057-1066. PubMed ID: 30232529 [TBL] [Abstract][Full Text] [Related]
18. Behavioral sensitization following concurrent exposure to mephedrone and D-amphetamine in female mice. Berquist MD; Peet MM; Baker LE Behav Pharmacol; 2015 Feb; 26(1-2):180-3. PubMed ID: 25485643 [TBL] [Abstract][Full Text] [Related]
19. The preclinical pharmacology of mephedrone; not just MDMA by another name. Green AR; King MV; Shortall SE; Fone KC Br J Pharmacol; 2014 May; 171(9):2251-68. PubMed ID: 24654568 [TBL] [Abstract][Full Text] [Related]
20. Effects of dopaminergic and serotonergic compounds in rats trained to discriminate a high and a low training dose of the synthetic cathinone mephedrone. Saber I; Milewski A; Reitz AB; Rawls SM; Walker EA Psychopharmacology (Berl); 2019 Mar; 236(3):1015-1029. PubMed ID: 30980094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]